The overall mission of the Oregon Alzheimer Disease Center (OADC) is to facilitate and advance research in Alzheimer disease (AD) and related dementias. This will be achieved by maintaining 6 Core facilities in association with expert Core personnel to support both current research strengths, as well as be responsive to the developing potential of new knowledge and discoveries in the field. The Center is organized and coordinated by the Administrative Core to be an efficient unit, working in concert with the research community to facilitate investigations in several major thematic areas such as studies of preclinical or incipient dementia in the very elderly, the genetics of AD, and the relationship between AD and Parkinson disease. The Clinical Core provides well-characterized, longitudinally followed research subjects of several kinds: 1) AD and related dementias; 2) Healthy elderly at high risk for developing dementia, emphasing those older than 85 years of age; 3) Parkinson dementias; and 4) Subjects reflecting social and racial diversity (African American, Native American, and isolated rural populations) in the context of gender differences. The Clinical Core and its subject resources are linked to the Neuropathology Core through programs designed to enhance tissue donation. The Neuropathology Core uses state-of-the-art biochemical, histopathologic and morphometric techniques to characterize donated tissues which in turn are utilized by a diverse array of basic and molecular scientists both locally and nationally. The Genetics Core responds to the needs of both Clinical and Neuropathology Cores and their missions of sophisticated characterization of research subjects and tissues by family history and genotype. The Genetics Core is also responsive to basic scientists in its potential ability to facilitate study of candidate genes causing AD or genes which are protective and promote successful aging. Linking all these units is the Data Management Core which maintains an efficient relational database containing a unique catalogue record system which allows easy revision and modification of protocols as is inevitable in any longitudinal program. The Data Management Core further provides important assistance and advice in design and statistical analysis to investigators beginning to develop new projects. Finally, the information and knowledge of the field is disseminated through the Education and Information Transfer Core. This Core provides regular educational forums of many types ranging from small seminars and lectures to interactive television broadcasts. New research is encouraged by the pilot project program. Four pilot projects are proposed for year 06 addressing the following topics: 1) estrogen and trk receptors in non- human primates; 2) gender differences in cognition and AD; glucose transporter deficit in AD; and 4) somatostatin's role in neurodegeneration through a gene 'knock-out' mouse model.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
3P30AG008017-09S1
Application #
2844105
Study Section
Special Emphasis Panel (ZAG1 (50))
Project Start
1990-07-06
Project End
2000-03-31
Budget Start
1998-08-01
Budget End
1999-03-31
Support Year
9
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Neurology
Type
Schools of Medicine
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Wardzala, Casia; Murchison, Charles; Loftis, Jennifer M et al. (2018) Sex differences in the association of alcohol with cognitive decline and brain pathology in a cohort of octogenarians. Psychopharmacology (Berl) 235:761-770
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Besser, Lilah; Kukull, Walter; Knopman, David S et al. (2018) Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. Alzheimer Dis Assoc Disord 32:351-358
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416

Showing the most recent 10 out of 482 publications